febuxostat has been researched along with Cardiotoxicity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, K; Kashiwagi, Y; Kimura, H; Nagoshi, T; Oi, Y; Takahashi, H; Tanaka, TD; Tanaka, Y; Yoshii, A; Yoshimura, M | 1 |
1 other study(ies) available for febuxostat and Cardiotoxicity
| Article | Year |
|---|---|
Xanthine oxidase inhibition attenuates doxorubicin-induced cardiotoxicity in mice.
Topics: Animals; Cardiotoxicity; Doxorubicin; Febuxostat; Mice; Uric Acid; Xanthine Oxidase | 2021 |